KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Inventory: 2014-2025

Historic Change in Inventory for Exact Sciences (EXAS) over the last 11 years, with Sep 2025 value amounting to -$6.7 million.

  • Exact Sciences' Change in Inventory fell 169.84% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year increase of 571.61%. This contributed to the annual value of $34.9 million for FY2024, which is 353.98% up from last year.
  • Exact Sciences' Change in Inventory amounted to -$6.7 million in Q3 2025, which was down 31.47% from -$5.1 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Change in Inventory registered a high of $25.4 million during Q4 2024, and its lowest value of -$6.7 million during Q3 2025.
  • In the last 3 years, Exact Sciences' Change in Inventory had a median value of $1.1 million in 2024 and averaged $4.1 million.
  • In the last 5 years, Exact Sciences' Change in Inventory surged by 1,670.17% in 2024 and then tumbled by 339.79% in 2025.
  • Exact Sciences' Change in Inventory (Quarterly) stood at $8.1 million in 2021, then plummeted by 56.63% to $3.5 million in 2022, then crashed by 252.69% to -$5.4 million in 2023, then soared by 571.68% to $25.4 million in 2024, then slumped by 169.84% to -$6.7 million in 2025.
  • Its Change in Inventory stands at -$6.7 million for Q3 2025, versus -$5.1 million for Q2 2025 and $14.2 million for Q1 2025.